331 indexable Biopharma Outsourcing companies headquartered in Maharashtra, India, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $679.9M across 34 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
Enzene
Company specializing in development of Biosimilars |
$50M | — | Series C | Series C Jan 2023 | 590 | 2015 | — |
| 2 |
Inventys
Custom based manufacturer of actives, crop protection, advanced intermediates, and specialty chemicals |
$64.3M | $249.3M as of 2022 |
Series A | Series A Apr 2022 | 197 | 2005 | — |
| 3 |
Hikal
Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates |
$69.4M | — | Public | Post IPO Nov 2021 | 346 | 1988 | — |
| 4 |
Encube Ethicals
Company offering contract development and manufacturing services for topical semisolid formulations |
$65.5M | $779.8M as of 2021 |
Series D | Series D Jun 2021 | 1,382 | 1998 | — |
| 5 |
Bilcare
Company offering innovative solutions for pharma packaging, clinical supplies and anti-counterfeiting |
$149.4M | — | Acquired | Conventional Debt Aug 2014 | 94 | 1993 | — |
| 6 |
Lozen Pharma
Manufacturer of medicated lozenges |
$7.3M | $21.9M as of 2023 |
Seed | Seed Jul 2023 | 111 | 2009 | — |
| 7 |
V-Ensure Pharma Technologies
CDMO focused on manufacturing of APIs |
$17.4M | $58.3M as of 2022 |
Late Stage | PE Feb 2022 | 221 | 2010 | — |
| 8 |
VS International
Manufacturer of pharmaceutical products, healthcare products, and medical devices |
$8.5M | $17.3M as of 2022 |
Series A | Angel Oct 2022 | 63 | 1997 | — |
| 9 |
Arch Pharmalabs
API manufacturer & supplier, also offering custom synthesis and contract manufacturing services |
$68M | — | Acquired | Series C Jan 2013 | 1 | 1999 | — |
| 10 |
Astec LifeSciences
Producer of Organic Intermediates for the pharmaceutical and Agrochemical Industries. |
$62M | — | Public | Post IPO Aug 2015 | 640 | 1994 | — |
| 11 |
Eurolife Healthcare
Manufacturer and distributor of healthcare formulations |
$20.1M | $42.5M as of 2019 |
Series A | Series A Dec 2019 | 55 | 2001 | — |
| 12 |
ZCL Chemicals
Manufacturer and exporter of intermediates and APIs for pharmaceutical applications |
$27.1M | $128M as of 2016 |
Acquired | Series B Dec 2016 | 1 | 1991 | — |
| 13 |
Enaltec Labs
Non-oncology API developer and manufacturer |
$8.6M | $1.6M as of 2022 |
Acquired | Series A Jan 2022 | 323 | 2006 | — |
| 14 |
Alpha MD
Provider of market access, regulatory affairs, and commercialization services for healthcare industry |
$5.3M | $5.9M as of 2021 |
Seed | Angel Jun 2021 | 31 | 2015 | — |
| 15 |
Zim Labs
Development services provider for solid and semisolid dosage forms |
$8.2M | — | Public | Grant (prize money) Jul 2021 | 591 | 1989 | — |
| 16 |
Clearsynth
CDMO focused on manufacturing of pharmaceutical small molecules and analytical research services |
$4.8M | $49.7M as of 2022 |
Series A | Series A Feb 2022 | 288 | 2009 | — |
| 17 |
MJ-Biopharma
Animal and human rDNA Insulin products and dosage forms |
$9.1M | $32.9M as of 2018 |
Acquired | Angel Sep 2019 | 265 | 2002 | — |
| 18 |
Ashish Life Science
Manufacturer of veterinary products |
$6.3M | — | Early Stage | Unattributed Jan 2019 | 235 | 1975 | — |
| 19 |
DiagnoSearch Life Sciences
Full-service CRO |
$7.2M | $82.4K as of 2010 |
Series A | Series A Aug 2010 | 82 | 1995 | — |
| 20 |
Cilicant
Manufacturer and supplier of drugs for biopharma sector |
$2M | $20.5M as of 2021 |
Seed | Seed Feb 2021 | 175 | 2011 | — |
| 21 |
Siro Clinpharm
Company offering clinical development services |
$5.3M | $37.4M as of 2009 |
Acquired | Series A Feb 2009 | 57 | 2000 | — |
| 22 |
Indus Biotech
Specialty company developing products for autoimmune, CNS, Infectious and lifestyle diseases |
$5.3M | — | Series A | Series A 2007 | 121 | 1997 | — |
| 23 |
IQGEN-X Pharma
Manufacturer of solid and liquid finished formulations |
$1.4M | $4.2M as of 2020 |
Seed | Seed Oct 2020 | 31 | 2016 | — |
| 24 |
EnEm Nostrum
Company focussed entirely on formulations research for identifying Novel Drug Delivery Systems for oral solid dosage forms |
$2.3M | — | Seed | Seed Feb 2016 | 375 | 2004 | — |
| 25 |
Karmic Lifesciences
CRO offering clinical management services |
$2M | — | Acquired | Series A May 2010 | 164 | 2005 | — |
| 26 |
Shantani Proteome Analytics
Drug discovery and development services using its chemical-proteomics technologies |
$1M | $2.6M as of 2014 |
Seed | Seed Jan 2015 | 10 | 2010 | — |
| 27 |
Yashraj Biotechnology
Provider of recombinant antigens and antibodies for diagnostic and research |
$491.6K | $18.7M as of 2019 |
Early Stage | Unattributed Oct 2019 | 272 | 1999 | — |
| 28 |
Khandelwal Laboratories
Manufacturer of APIs and formulations, with a special focus on oncology |
$459.3K | $1.2M as of 2007 |
Early Stage | Mar 2007 | 788 | 1945 | — |
| 29 |
Embio
Contract research and manufacturing company engaged in APIs and chiral intermediates |
$292.4K | — | Early Stage | Unattributed Oct 2018 | 611 | 1986 | — |
| 30 |
Genesis Ingredients
Manufacturer of pharmaceutical ingredients |
$132.1K | $4.1M as of 2021 |
Seed | Mar 2021 | — | 2009 | — |
| 31 |
Ethosh
Provider of digital experience and marketing services to health-tech and life-sciences organizations |
$275.1K | $1.1M as of 2016 |
Seed | Angel Dec 2016 | 37 | 2012 | — |
| 32 |
Fabtech
Provider of instruments for biotech, pharmaceutical, and biomedical industries |
$175K | $31M as of 2012 |
Public | Seed Feb 2012 | 1 | 2002 | — |
| 33 |
Indo Bioactive Labs
Company offering CDMO services for the development of heparin and peptide-based therapeutics |
$115.1K | $116.5K as of 2007 |
Seed | Seed Mar 2007 | — | 2001 | — |
| 34 |
Techizer
Provider of marketing software for pharmacies |
$84.8K | $338.5K as of 2017 |
Seed | Seed Mar 2017 | 15 | 2011 | — |
| 35 |
Techinvention
Provider of vaccines, diagnostics, and bio-therapeutics services |
— | — | Seed | Angel Dec 2025 | 36 | 2016 | ↑ Active |
| 36 |
SCHOTT Poonawalla
Provider of packaging products for the pharmaceutical and biotech industries |
— | — | Late Stage | PE May 2025 | 1,297 | 1990 | ↑ Active |
| 37 |
aSai Vishwa Speciality Chemicals
Manufacturer of APIs and specialty chemicals |
— | $2.5M as of 2018 |
Seed | Seed Mar 2018 | 31 | 2012 | — |
| 38 |
Ideal Cures
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms |
— | — | Acquired | PE Mar 2017 | 113 | 1999 | — |
| 39 |
Indoco Remedies
Provider of APIs manufacturing and formulation services |
— | — | Public | Post IPO Feb 2012 | 914 | 1947 | — |
| 40 |
Geneombio Technologies
Provider of molecular diagnostic, contract research and animal genetic services |
— | $5.2M as of 2009 |
Seed | Angel Jul 2009 | 35 | 2005 | — |
| 41 |
SP Pharmaceuticals
Manufacturer of pharmaceutical tablets, liquids, and granules |
— | — | Late Stage | PE 1997 | — | 1996 | — |
| 42 |
3A Chemie
Manufacturer of fine chemicals for pharmaceutical industries |
— | — | Unfunded | — | 25 | 1994 | — |
| 43 |
Aadivignesh
Provider of active pharmaceutical ingredients, herbal extracts, veterinary and probiotic products |
— | — | Unfunded | — | — | 2009 | — |
| 44 |
Aaquaries
CDMO focused on manufacturing API for biopharma industry |
— | — | Unfunded | — | — | 2007 | — |
| 45 |
Aarey Drugs & Pharmaceuticals
API's and Bulk Drugs manufacturer |
— | — | Public | — | 69 | 1993 | — |
| 46 |
Aarti Drugs
APIs, intermediates and domestic formulations manufacturer |
— | — | Public | — | 448 | 1984 | — |
| 47 |
Aarti Pharmalabs
Manufacturer of active pharmaceutical ingredients, intermediates, and new chemical entities |
— | — | Public | — | 2,149 | 2019 | — |
| 48 |
AB Bioproducts India
CDMO focused on manufacturing pharmaceutical supplements |
— | — | Unfunded | — | — | 2011 | — |
| 49 |
Abhiflax Pharma Chem
Manufacturer of pharmaceutical finished formulations |
— | — | Unfunded | — | — | 1994 | — |
| 50 |
Abhis Pharma Specialties
Manufacturer of tablets, capsules, syrup, and injectables |
— | — | Deadpooled | — | — | 2007 | — |
Enzene Biosciences Ltd., a subsidiary of Alkem Laboratories Limited, is uniquely poised to lead the new wave of global biosimilars development. Enzene has established several technology platforms in the areas of molecular biology, protein expression, fermentation technology (microbial, insect and mammalian cells), bio-analytics, immunology and peptide synthesis. The areas of expertise are: Proprietary expression vect
Custom based manufacturer of actives, crop protection, advanced intermediates, and specialty chemicals. The company provides custom synthesis, contract development, and manufacturing services, delivering high-quality solutions tailored to client needs. It provides primarily advanced intermediates and registered starting materials for pharma, fine chemicals, and the electronics industry.
Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates. Company supplies active ingredients for pharmaceutical and medicine manufacturing, as well as other chemical product and preparation manufacturing. Company provides intermediates for the production of various chemicals and pharmaceuticals. It offers research and development services to help companies in
Company offering contract development and manufacturing services for topical semisolid formulations. It offers development services such as formulation development, analytical development, packaging development, lab scale stability study as per ICH guidelines, and scale-up & commercialisation for topical semi-solid formulations. Its manufacturing facility produces different semisolid formulations such as ointments, g
Bilcare is a pharma packaging solutions provider. The company has 3 major divisions - Pharmaceutical Packaging International (PPI), Global Clinical Material Supplies (GCS) and non-clonable ID technologies. The PPI division offers packaging solutions mainly for solid dose packaging through specialty Polymer Films and Aluminum Foils. The GCS division offers clinical trial supply management services such as clinical sup
Manufacturer of medicated lozenges
CDMO focused on manufacturing of APIs
Manufacturer of pharmaceutical products, healthcare products, and medical devices. This entity engages in the manufacturing, marketing, and export of these products. It operates a manufacturing plant with several regulatory accreditations. The company also provides contract manufacturing services to partners. In-house research and development capabilities support product innovation and development.
Arch Pharmalabs, is a provider of small molecule process chemistry, custom synthesis services and full life-cycle API and drug intermediates and manufacture for the global pharmaceutical industry. In Sep'2010 Japanese conglomerate Mitsui has bought a 5% stake in Arch Pharmalabs, for around INR 65 crore and additional 25% in Sept'2012 for INR 372 Crore. Mitsui bought out the stakes of IL&FS Trust Co, IDBI Trusteesh
Astec LifeSciences is an Indian manufacturer of agrochemical active ingredients, formulations and intermediate products. Astec is a leader in Triazole fungicides and has a portfolio of fungicide and herbicide technical products for Indian and global markets. The Company has 214 product registrations across 32 countries including 139 product registrations in India. As of August 2015, Godrej Agrovet had given
Manufacturer and distributor of healthcare formulations. Its portfolio includes intravenous infusions, ophthalmics, sterilized water for injections, nebules, tablets, capsules, ointments, creams, classic infusion therapy, topicals, lifeflow, germkill, nutrition and drugs, lifeport, and anti-infectives. It also offers marketing and regulatory support services for pharmaceutical products.
Manufacturer and exporter of intermediates and APIs for pharmaceutical applications. The company specializes in manufacturing APIs and intermediates for niche therapeutic areas such as CNS diseases, antiretrovirals, and controlled substances. The company also offers contract custom synthesis and development services for its customers.
BIRAC
C-CAMP
SIDBI Venture Capital
Startups at Venture Center
Baring Private Equity Partners
Blume Venture
Department of Biotechnology
Eight Roads Ventures
SINE
3i Group
ACG Group
AL
Acaciaa International TR LLC
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-18.
_1581421310376.png){kind=logo}
_1530180465228.png){kind=logo}
_1571642277342.png){kind=logo}
.png1511873407986){kind=logo}
.png1511949519320){kind=logo}
.png1512729242052){kind=logo}
